Kolosis BIO
William Borghetti is the Chief Executive Officer of Title iO, where William previously served as Chairman of the Board. William is also the CEO of REVvy Technologies, a company focused on building the information infrastructure for "Real Estate 3.0". Additionally, William is the Managing Director of Kolosis BIO, a company that provides pure cortical bone graft tissues. Borghetti is the Founder and former CEO of Daffinity Technology Ventures, a technology development and investment company. William has also served as the CEO of APiO, Inc. and Sendside Networks, Inc., a secure communication and document delivery company. Borghetti holds a BS in Finance from the University of Utah.
Kolosis BIO
Kolosis BIO is a leading provider of innovative surgical products primarily in the spine and orthopedic market. As a pure-play biologics company, Kolosis exclusively partners with MTF Biologics to offer superior quality allograft technologies that are backed by MTF’s proprietary processing methods. Kolosis is dedicated to driving innovation and expanding its product offerings, pushing the boundaries of science to enhance patient outcomes.